
|Videos|July 20, 2016
Nickhill Bhakta on the Burden of Adult Survivors of Pediatric Cancer
Author(s)Nickhill Bhakta, MD
Nickhill Bhakta, MD, fellow at St. Jude Children’s Research Hospital, discusses disease burden on adult survivors of pediatric cancer.
Advertisement
Nickhill Bhakta, MD, fellow at St. Jude Children’s Research Hospital, discusses disease burden on adult survivors of pediatric cancer.
As cure rates for some childhood cancers reach 80% to 90%, understanding the late effects of treatment is becoming increasingly important to investigate. Researchers and doctors are also asking how treatment, specifically radiation and chemotherapy, can be altered to reduce certain effects later in life.
But what is still lacking is an understanding of the total morbidity that adult survivors of pediatric cancers are facing.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Camizestrant Approval: Nurses Key to New Breast Cancer Paradigm
2
FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care
3
Nursing Protocols for the New Oral RAS Inhibitor Daraxonrasib
4
FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer
5



























































